In Hiroshima, Tresiba (Insulin Degludec) Effect and Safty in Diabetes study
Not Applicable
- Conditions
- Diabetes mellitus
- Registration Number
- JPRN-UMIN000011037
- Lead Sponsor
- Hiroshima University Hospital Department of Endocrinology and Metabolism
- Brief Summary
J Diabetes Investig. 2016 Jan;7(1):94-9. doi: 10.1111/jdi.12373. Epub 2015 Jun 10. Efficacy and safety of insulin degludec in Japanese patients with type1 and type2 diabetes: 24-week results from the observational study in routine clinical practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1. who use insulin only short term 2. women in pregnant or during lactation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method achievment rate of HbA1c <6.9%
- Secondary Outcome Measures
Name Time Method number of all adverse events, achievment rate of fasting blood glucose < 80-100 mg/dl, variation of HbA1c, variation of fasting blood glucose and blood glucose before dinner, variation of body weight, number of all low blood glucose phenomenon